Chemed Corporation CHE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.66B | 2.60B | 2.54B | 2.53B | 2.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.66B | 2.60B | 2.54B | 2.53B | 2.53B |
| Cost of Revenue | 1.77B | 1.73B | 1.72B | 1.70B | 1.70B |
| Gross Profit | 895.37M | 862.16M | 825.39M | 826.03M | 834.98M |
| SG&A Expenses | 443.80M | 438.10M | 423.22M | 414.49M | 415.94M |
| Depreciation & Amortization | 67.59M | 66.42M | 65.70M | 64.84M | 64.34M |
| Other Operating Expenses | -155.00K | -155.00K | -207.00K | -148.00K | -211.00K |
| Total Operating Expenses | 2.28B | 2.24B | 2.20B | 2.18B | 2.18B |
| Operating Income | 384.14M | 357.79M | 336.67M | 346.85M | 354.91M |
| Income Before Tax | 382.32M | 369.16M | 348.94M | 355.78M | 370.46M |
| Income Tax Expenses | 99.92M | 94.17M | 89.16M | 90.54M | 91.65M |
| Earnings from Continuing Operations | 282.40 | 274.99 | 259.78 | 265.24 | 278.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 282.40M | 274.99M | 259.78M | 265.24M | 278.81M |
| EBIT | 384.14M | 357.79M | 336.67M | 346.85M | 354.91M |
| EBITDA | 447.43M | 419.92M | 398.07M | 407.39M | 414.96M |
| EPS Basic | 20.96 | 19.93 | 18.39 | 18.45 | 19.05 |
| Normalized Basic EPS | 18.35 | 17.11 | 15.82 | 15.85 | 15.97 |
| EPS Diluted | 20.90 | 19.91 | 18.35 | 18.37 | 18.92 |
| Normalized Diluted EPS | 18.30 | 17.09 | 15.79 | 15.78 | 15.85 |
| Average Basic Shares Outstanding | 53.90M | 55.24M | 56.65M | 57.60M | 58.46M |
| Average Diluted Shares Outstanding | 54.03M | 55.31M | 56.81M | 57.89M | 58.87M |
| Dividend Per Share | 2.50 | 2.40 | 2.30 | 2.20 | 2.10 |
| Payout Ratio | 11.94% | 12.07% | 12.53% | 11.95% | 11.01% |